UA73718C2 - Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof - Google Patents

Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof Download PDF

Info

Publication number
UA73718C2
UA73718C2 UA2000116863A UA2000116863A UA73718C2 UA 73718 C2 UA73718 C2 UA 73718C2 UA 2000116863 A UA2000116863 A UA 2000116863A UA 2000116863 A UA2000116863 A UA 2000116863A UA 73718 C2 UA73718 C2 UA 73718C2
Authority
UA
Ukraine
Prior art keywords
feline
virus
gene
recombinant
cat
Prior art date
Application number
UA2000116863A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of UA73718C2 publication Critical patent/UA73718C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70532B7 molecules, e.g. CD80, CD86
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16041Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/60Vector systems having a special element relevant for transcription from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
UA2000116863A 1998-05-01 1999-04-30 Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof UA73718C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7171198A 1998-05-01 1998-05-01
PCT/US1999/009504 WO1999057295A1 (en) 1998-05-01 1999-04-30 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof

Publications (1)

Publication Number Publication Date
UA73718C2 true UA73718C2 (en) 2005-09-15

Family

ID=22103082

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000116863A UA73718C2 (en) 1998-05-01 1999-04-30 Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof

Country Status (20)

Country Link
EP (1) EP1073759B1 (ja)
JP (2) JP2002513581A (ja)
KR (1) KR100796799B1 (ja)
AT (1) ATE511545T1 (ja)
AU (1) AU761755B2 (ja)
BR (1) BR9915970A (ja)
CA (1) CA2327528C (ja)
CZ (1) CZ20003934A3 (ja)
ES (1) ES2367245T3 (ja)
HK (1) HK1032606A1 (ja)
HU (1) HUP0200320A3 (ja)
IL (2) IL139372A0 (ja)
NO (1) NO20005482L (ja)
NZ (1) NZ507793A (ja)
PL (1) PL199359B1 (ja)
RU (1) RU2244006C2 (ja)
SK (1) SK16162000A3 (ja)
UA (1) UA73718C2 (ja)
WO (1) WO1999057295A1 (ja)
ZA (1) ZA200006124B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078512B2 (en) 1998-05-01 2006-07-18 Schering-Plough Animal Health Corporation Nucleic acid encoding feline CD86
WO2001024764A2 (en) * 1999-10-06 2001-04-12 The Trustees Of The University Of Pennsylvania Cell targeting compositions and methods of using the same
CN101137674A (zh) 2005-03-08 2008-03-05 肯顿有限公司 刚地弓形虫的嵌合重组抗原
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus
BR112018069371A2 (pt) 2016-03-21 2019-01-22 South Dakota Board Of Regents construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1645635A3 (en) * 1989-08-18 2010-07-07 Oxford Biomedica (UK) Limited Replication defective recombinant retroviruses expressing a palliative
DK0576092T3 (da) * 1992-06-26 2003-02-17 Akzo Nobel Nv Rekombineret felin herbesvirusvaccine
DE69332480T2 (de) * 1992-07-30 2003-07-17 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff-vektoren von rekombinantem katzen-herpesvirus
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ES2154738T3 (es) * 1994-10-03 2001-04-16 Us Gov Health & Human Serv Composicion que comprende un virus recombinante que expresa un antigeno y un virus recombinante que expresa una molecula inmunoestimuladora.
US6221361B1 (en) * 1995-01-19 2001-04-24 Syntro Corporation Recombinant swinepox virus
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection

Also Published As

Publication number Publication date
JP2009178163A (ja) 2009-08-13
NO20005482L (no) 2000-12-27
AU3968899A (en) 1999-11-23
IL139372A0 (en) 2001-11-25
PL199359B1 (pl) 2008-09-30
CA2327528A1 (en) 1999-11-11
KR100796799B1 (ko) 2008-01-22
EP1073759B1 (en) 2011-06-01
JP2002513581A (ja) 2002-05-14
HUP0200320A2 (hu) 2002-05-29
NZ507793A (en) 2003-05-30
AU761755B2 (en) 2003-06-12
IL139372A (en) 2010-11-30
ZA200006124B (en) 2002-04-02
CA2327528C (en) 2010-10-12
NO20005482D0 (no) 2000-10-31
CZ20003934A3 (cs) 2001-09-12
RU2244006C2 (ru) 2005-01-10
EP1073759A1 (en) 2001-02-07
ES2367245T8 (es) 2011-12-09
WO1999057295A1 (en) 1999-11-11
ATE511545T1 (de) 2011-06-15
HUP0200320A3 (en) 2006-03-28
KR20010085242A (ko) 2001-09-07
SK16162000A3 (sk) 2001-12-03
HK1032606A1 (en) 2001-07-27
BR9915970A (pt) 2001-12-04
ES2367245T3 (es) 2011-10-31
PL346012A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
US6537594B1 (en) Vaccina virus comprising cytokine and/or tumor associated antigen genes
Franceschi et al. Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen
US6780407B1 (en) Pox virus comprising DNA sequences encoding CEA and B7 antigen
JP2000500115A (ja) 組換え体ポックスウイルス−狂犬病組成物および組合せ組成物並びに使用
JP2001520507A (ja) 組換えポックスウイルス−サイトメガロウイルス組成物および使用
WO2004076645A2 (en) Compositions and methods for cytomegalovirus treatment
TWI295322B (en) Capsid protein of feline calicivirus strain 431 and g1, dna fragments encoding them and immunogenic preparation comprising the same
HUT62325A (en) Chicken anaemia virus vaccine and diagnostic
WO1992004460A1 (en) Genetically engineered coccidiosis vaccine
US5661006A (en) DNA encoding the Canine coronavirus spike protein
UA73718C2 (en) Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof
JPH11511961A (ja) 組換えポックスウイルス−カリシウイルス[ウサギ出血疾患ウイルス(rhdv)]組成物および使用
JPH09503647A (ja) 組換えブタポックスウイルス
CA2127700C (en) Marek's disease virus recombinant poxvirus vaccine
KR20240019135A (ko) 작제물과 면역자극 화합물의 공동발현
CN115819614A (zh) 一种基于il34的嵌合抗原受体免疫细胞制备及其应用
CN115806626A (zh) 一种基于csf1的嵌合抗原受体免疫细胞制备及其应用
Redwood et al. Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector
EP0830452A1 (en) Immune-evading proteins
US7279168B2 (en) Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
UA77382C2 (en) Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat
KR20210084125A (ko) 신규 사이토메갈로바이러스 dna 백신 컨스트럭트 및 그의 용도
WO2019145739A1 (en) Lassa virus antigenic composition
Munro et al. Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus
ITMI950676A1 (it) Vaccini polinucleotidici